An open-label trial of aripiprazole treatment in dual diagnosis individuals: Safety and efficacy

Aimee L. McRae-Clark, Marcia L. Verduin, Bryan K. Tolliver, Rickey E. Carter, Amy E. Wahlquist, Kathleen T. Brady, Jeffrey S. Cluver, Samantha Anderson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This open-label study evaluated the safety and efficacy of aripiprazole in the treatment of 20 patients with co-morbid schizophrenia, schizoaffective disorder, or bipolar disorder and alcohol, cocaine, and/or marijuana use disorders. Primary outcomes were substance use, measured by the Timeline Followback, and score on the Clinical Global Impression scale for psychiatric and substance use symptoms. The data suggest that aripiprazole may reduce substance use and improve psychiatric symptoms in patients with co-morbid disorders; however, limitations are noted. Subsequent randomized studies are needed to further explore these findings.

Original languageEnglish (US)
Pages (from-to)83-96
Number of pages14
JournalJournal of Dual Diagnosis
Volume5
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Dual (Psychiatry) Diagnosis
Psychiatry
Safety
Cannabis
Bipolar Disorder
Cocaine
Psychotic Disorders
Schizophrenia
Alcohols
Therapeutics
Aripiprazole
TimeLine

Keywords

  • Alcohol
  • Aripiprazole
  • Cocaine
  • Dual diagnosis
  • Marijuana

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

McRae-Clark, A. L., Verduin, M. L., Tolliver, B. K., Carter, R. E., Wahlquist, A. E., Brady, K. T., ... Anderson, S. (2009). An open-label trial of aripiprazole treatment in dual diagnosis individuals: Safety and efficacy. Journal of Dual Diagnosis, 5(1), 83-96. https://doi.org/10.1080/15504260802620210

An open-label trial of aripiprazole treatment in dual diagnosis individuals : Safety and efficacy. / McRae-Clark, Aimee L.; Verduin, Marcia L.; Tolliver, Bryan K.; Carter, Rickey E.; Wahlquist, Amy E.; Brady, Kathleen T.; Cluver, Jeffrey S.; Anderson, Samantha.

In: Journal of Dual Diagnosis, Vol. 5, No. 1, 01.2009, p. 83-96.

Research output: Contribution to journalArticle

McRae-Clark, AL, Verduin, ML, Tolliver, BK, Carter, RE, Wahlquist, AE, Brady, KT, Cluver, JS & Anderson, S 2009, 'An open-label trial of aripiprazole treatment in dual diagnosis individuals: Safety and efficacy', Journal of Dual Diagnosis, vol. 5, no. 1, pp. 83-96. https://doi.org/10.1080/15504260802620210
McRae-Clark, Aimee L. ; Verduin, Marcia L. ; Tolliver, Bryan K. ; Carter, Rickey E. ; Wahlquist, Amy E. ; Brady, Kathleen T. ; Cluver, Jeffrey S. ; Anderson, Samantha. / An open-label trial of aripiprazole treatment in dual diagnosis individuals : Safety and efficacy. In: Journal of Dual Diagnosis. 2009 ; Vol. 5, No. 1. pp. 83-96.
@article{02c51b3c9f924e6c82a04255d351cab3,
title = "An open-label trial of aripiprazole treatment in dual diagnosis individuals: Safety and efficacy",
abstract = "This open-label study evaluated the safety and efficacy of aripiprazole in the treatment of 20 patients with co-morbid schizophrenia, schizoaffective disorder, or bipolar disorder and alcohol, cocaine, and/or marijuana use disorders. Primary outcomes were substance use, measured by the Timeline Followback, and score on the Clinical Global Impression scale for psychiatric and substance use symptoms. The data suggest that aripiprazole may reduce substance use and improve psychiatric symptoms in patients with co-morbid disorders; however, limitations are noted. Subsequent randomized studies are needed to further explore these findings.",
keywords = "Alcohol, Aripiprazole, Cocaine, Dual diagnosis, Marijuana",
author = "McRae-Clark, {Aimee L.} and Verduin, {Marcia L.} and Tolliver, {Bryan K.} and Carter, {Rickey E.} and Wahlquist, {Amy E.} and Brady, {Kathleen T.} and Cluver, {Jeffrey S.} and Samantha Anderson",
year = "2009",
month = "1",
doi = "10.1080/15504260802620210",
language = "English (US)",
volume = "5",
pages = "83--96",
journal = "Journal of Dual Diagnosis",
issn = "1550-4263",
publisher = "Routledge",
number = "1",

}

TY - JOUR

T1 - An open-label trial of aripiprazole treatment in dual diagnosis individuals

T2 - Safety and efficacy

AU - McRae-Clark, Aimee L.

AU - Verduin, Marcia L.

AU - Tolliver, Bryan K.

AU - Carter, Rickey E.

AU - Wahlquist, Amy E.

AU - Brady, Kathleen T.

AU - Cluver, Jeffrey S.

AU - Anderson, Samantha

PY - 2009/1

Y1 - 2009/1

N2 - This open-label study evaluated the safety and efficacy of aripiprazole in the treatment of 20 patients with co-morbid schizophrenia, schizoaffective disorder, or bipolar disorder and alcohol, cocaine, and/or marijuana use disorders. Primary outcomes were substance use, measured by the Timeline Followback, and score on the Clinical Global Impression scale for psychiatric and substance use symptoms. The data suggest that aripiprazole may reduce substance use and improve psychiatric symptoms in patients with co-morbid disorders; however, limitations are noted. Subsequent randomized studies are needed to further explore these findings.

AB - This open-label study evaluated the safety and efficacy of aripiprazole in the treatment of 20 patients with co-morbid schizophrenia, schizoaffective disorder, or bipolar disorder and alcohol, cocaine, and/or marijuana use disorders. Primary outcomes were substance use, measured by the Timeline Followback, and score on the Clinical Global Impression scale for psychiatric and substance use symptoms. The data suggest that aripiprazole may reduce substance use and improve psychiatric symptoms in patients with co-morbid disorders; however, limitations are noted. Subsequent randomized studies are needed to further explore these findings.

KW - Alcohol

KW - Aripiprazole

KW - Cocaine

KW - Dual diagnosis

KW - Marijuana

UR - http://www.scopus.com/inward/record.url?scp=61649093994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61649093994&partnerID=8YFLogxK

U2 - 10.1080/15504260802620210

DO - 10.1080/15504260802620210

M3 - Article

AN - SCOPUS:61649093994

VL - 5

SP - 83

EP - 96

JO - Journal of Dual Diagnosis

JF - Journal of Dual Diagnosis

SN - 1550-4263

IS - 1

ER -